Stock HEPA HEPION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Hepion Pharmaceuticals, Inc.

Equities

HEPA

US4268973025

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
1.49 USD +5.67% Intraday chart for Hepion Pharmaceuticals, Inc. -26.96% -54.01%
Apr. 22 Sector Update: Health Care Stocks Increase Late Afternoon MT
Apr. 22 Sector Update: Health Care MT

Evolution of the average Target Price on Hepion Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

524ae5f5b853ae46937d27738e0b.u_O7aTuvXcZ9tqYNo2ha2eK2OsbN1QZ2WxWEJ_Fiqbc.74WIAVmbE48MgsxP0TEIoJHYSIqvv3MaMV_raIgH--HMy9MGd5tuvCiD8w~fc1ec4e5f028604982645e692230df4a

Analyst Recommendations on Hepion Pharmaceuticals, Inc.

Cantor Fitzgerald Starts Hepion Pharmaceuticals at Overweight With $3.50 Price Target MT
HEPION PHARMACEUTICALS : Roth Capital Adjusts Price Target on Hepion Pharmaceuticals to $8 From $14, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.49 USD
Average target price
30 USD
Spread / Average Target
+1,913.42%
High Price Target
30 USD
Spread / Highest target
+1,913.42%
Low Price Target
30 USD
Spread / Lowest Target
+1,913.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Hepion Pharmaceuticals, Inc.

Cantor Fitzgerald

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HEPA Stock
  4. Consensus Hepion Pharmaceuticals, Inc.